Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 617
Filter
1.
Contact Dermatitis ; 90(6): 585-593, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38417425

ABSTRACT

INTRODUCTION: Intensified hand hygiene measures were recommended for preventing the spread of SARS-CoV-2. However, these measures can lead to skin damage and the development of hand eczema, particularly among health professionals. OBJECTIVES: This pilot study aimed to evaluate the effects of repeated antiseptic use on healthy skin under controlled conditions and to assess the emollient use. METHODS: Twelve healthy volunteers (nine females, age = 22.3 ± 2.8 years (mean ± SD), Fitzpatrick phototypes II and III) with no skin diseases were recruited. Antiseptic was applied daily for 3 weeks on the volar sides of forearms. Emollient cream was also applied daily. Skin assessments were performed using non-invasive methods (transepidermal water loss-TEWL, skin hydration, erythema and melanin content). RESULTS: Prolonged antiseptic use increased TEWL, decreased hydration and elevated erythema and melanin levels. Emollient cream significantly reduced TEWL and improved hydration on antiseptic-treated sites, and also enhanced hydration on intact skin. CONCLUSIONS: Prolonged use of antiseptics can have adverse effects on the skin, including barrier disruption and inflammation. Emollient showed promise in improving skin hydration and reducing the damage caused by antiseptics. Further research with a larger sample is needed to confirm these findings and assess emollient efficacy during frequent antiseptic use.


Subject(s)
Anti-Infective Agents, Local , Emollients , Humans , Female , Pilot Projects , Anti-Infective Agents, Local/adverse effects , Male , Emollients/adverse effects , Young Adult , Adult , Erythema/chemically induced , Erythema/prevention & control , Water Loss, Insensible/drug effects , Skin/drug effects , Melanins , COVID-19/prevention & control
2.
Nutrients ; 13(12)2021 Dec 06.
Article in English | MEDLINE | ID: mdl-34959923

ABSTRACT

The stratum corneum (SC) is the outermost layer of the epidermis and plays an important role in maintaining skin moisture and protecting the skin from the external environment. Ceramide and natural moisturizing factor (NMF) are the major SC components that maintain skin moisture. In this study, we investigated whether the oral intake of enzymatically decomposed AP collagen peptides (APCPs) can improve skin moisture and barrier function by assessing changes in the ceramide and NMF contents in the SC after APCP ingestion with the aim to develop a skin functional food. Fifty participants orally ingested APCP (1000 mg) or placebo for 12 weeks, and then, skin hydration and skin texture were evaluated. SC samples were collected to analyze skin scaling, ceramide, and NMF contents. Participants in the APCP group exhibited improved skin moisture content by 7.33% (p = 0.031) and roughness by -4.09% (p = 0.036) when compared with those in the placebo group. NMF content; the amounts of amino acids (AA), including glycine and proline; and AA derivatives were significantly increased in the APCP group (31.98 µg/mg protein) compared to those in the placebo group (-16.01 µg/mg protein) (p = 0.006). The amounts of total ceramides and ceramide subclasses were significantly higher in the APCP group than in the placebo group (p = 0.014). In conclusion, our results demonstrate that APCP intake improves skin moisture and increase the ceramide and NMF contents in the SC, thereby enhancing the skin barrier function.


Subject(s)
Body Water/metabolism , Ceramides/metabolism , Collagen/administration & dosage , Collagen/pharmacology , Dietary Supplements , Eating/physiology , Epidermis/metabolism , Adult , Female , Humans , Male , Middle Aged , Water Loss, Insensible/drug effects
3.
Mar Drugs ; 19(11)2021 Nov 01.
Article in English | MEDLINE | ID: mdl-34822493

ABSTRACT

Atopic dermatitis (AD) is a chronic inflammatory skin disease in which skin barrier dysfunction leads to dryness, pruritus, and erythematous lesions. AD is triggered by immune imbalance and oxidative stress. Echinochrome A (Ech A), a natural pigment isolated from sea urchins, exerts antioxidant and beneficial effects in various inflammatory disease models. In the present study, we tested whether Ech A treatment alleviated AD-like skin lesions. We examined the anti-inflammatory effect of Ech A on 2,4-dinitrochlorobenzene (DNCB)-induced AD-like lesions in an NC/Nga mouse model. AD-like skin symptoms were induced by treatment with 1% DNCB for 1 week and 0.4% DNCB for 5 weeks in NC/Nga mice. The results showed that Ech A alleviated AD clinical symptoms, such as edema, erythema, and dryness. Treatment with Ech A induced the recovery of epidermis skin lesions as observed histologically. Tewameter® and Corneometer® measurements indicated that Ech A treatment reduced transepidermal water loss and improved stratum corneum hydration, respectively. Ech A treatment also inhibited inflammatory-response-induced mast cell infiltration in AD-like skin lesions and suppressed the expression of proinflammatory cytokines, such as interferon-γ, interleukin-4, and interleukin-13. Collectively, these results suggest that Ech A may be beneficial for treating AD owing to its anti-inflammatory effects.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Naphthoquinones/pharmacology , Sea Urchins , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/chemistry , Aquatic Organisms , Dermatitis, Atopic/drug therapy , Disease Models, Animal , Interleukin-3/metabolism , Male , Mice , Mice, Inbred Strains , Naphthoquinones/administration & dosage , Naphthoquinones/chemistry , Skin/drug effects , Water Loss, Insensible/drug effects
4.
Int J Mol Sci ; 22(19)2021 Sep 22.
Article in English | MEDLINE | ID: mdl-34638528

ABSTRACT

Dry and eczema-prone skin conditions such as atopic dermatitis and xerotic eczema primarily indicate an impaired skin barrier function, which leads to chronic pruritus. Here, we investigated the effects of a novel emollient containing H.ECMTM liposome, which contains a soluble proteoglycan in combination with hydrolyzed collagen and hyaluronic acid. A prospective, single-arm study was conducted on 25 participants with mild atopic dermatitis or dry skin to assess the hydration and anti-inflammatory effect of the novel emollient applied daily over four weeks. All efficacy parameters, including itching severity, transepidermal water loss, and skin hydration, improved significantly after four weeks. The in vitro and ex vivo studies confirmed the restoration of the skin's barrier function. The study revealed the clinical and laboratory efficacy of H.ECMTM liposome in reducing itching and improving the skin's barrier integrity. Thus, the use of H.ECMTM liposome can be considered a therapeutic option for dry and eczema-prone skin.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Collagen/pharmacology , Dermatitis, Atopic/drug therapy , Eczema/drug therapy , Hyaluronic Acid/pharmacology , Proteoglycans/pharmacology , Administration, Topical , Adult , Animals , Anti-Inflammatory Agents/administration & dosage , Cell Line , Collagen/administration & dosage , Dermatitis, Atopic/pathology , Emollients/pharmacology , Female , Humans , Hyaluronic Acid/administration & dosage , Ichthyosis/drug therapy , Liposomes/chemistry , Liposomes/pharmacology , Male , Mice , Middle Aged , Pilot Projects , Proteoglycans/administration & dosage , Pruritus/drug therapy , RAW 264.7 Cells , Severity of Illness Index , Skin/drug effects , Skin/pathology , Water Loss, Insensible/drug effects , Young Adult
5.
Mar Drugs ; 19(10)2021 Sep 28.
Article in English | MEDLINE | ID: mdl-34677449

ABSTRACT

Echinochrome A (Ech A, 7-ethyl-2,3,5,6,8-pentahydroxy-1,4-naphthoquinone) has been known to exhibit anti-oxidative and anti-inflammatory effects. However, no study has been carried out on the efficacy of Ech A against skin photoaging; this process is largely mediated by oxidative stress. Six-week-old male SKH-1 hairless mice (n = 36) were divided into five groups. Except for a group that were not treated (n = 4), all mice underwent ultraviolet-B (UVB) exposure for 8 weeks while applying phosphate-buffered saline or Ech A through intraperitoneal injection. UVB impaired skin barrier function, showing increased transepidermal water loss and decreased stratum corneum hydration. UVB induced dermal collagen degeneration and mast cell infiltration. Ech A injection was found to significantly lower transepidermal water loss while attenuating tissue inflammatory changes and collagen degeneration compared to the control. Furthermore, Ech A was found to decrease the relative expression of matrix metalloproteinase, tryptase, and chymase. Taken together, these results suggest that Ech A protects against UVB-induced photoaging in both functional and histologic aspects, causing a lowering of collagen degradation and inflammatory cell infiltration.


Subject(s)
Collagen/metabolism , Naphthoquinones/pharmacology , Protective Agents/pharmacology , Skin Aging/drug effects , Animals , Aquatic Organisms , Disease Models, Animal , Male , Mast Cells/drug effects , Mice , Mice, Hairless , Naphthoquinones/administration & dosage , Protective Agents/administration & dosage , Ultraviolet Rays , Water Loss, Insensible/drug effects
6.
Pak J Pharm Sci ; 34(3): 981-986, 2021 May.
Article in English | MEDLINE | ID: mdl-34602422

ABSTRACT

Skin care formulations with antioxidants are being widely explored for their benefits to human skin. The purpose of this study was to formulate a stable w/o emulsion containing anthocyanin derived from Malus dosmestica fruit extract and to further explore its beneficial effects on normal human skin. Anthocyanin was extracted using various solvents from the peel of Malus dosmestica fruit. w/o creams containing anthocyanin has been prepared and systematically characterized for various physiochemical properties in terms of stability at varying conditions of storage. An efficacy study has been carried out on 12 male healthy Asian subjects to determine effects of anthocyanin on skin melanin, erythema, skin moisture, trans-epidermal water loss (TEWL) and on skin sebum. Solvent system containing methanol/acetone/water (3.5: 3.5: 3 v/v/v) including 1% formic acid established a best recovery of anthocyanin from fruit peel. W/O emulsions presented promising stability profile when kept at different storage conditions over 90 days period. All skin parameters studied, anthocyanin has been found more efficacious (p<0.05) for its effects on skin melanin and erythema content of skin. It has been shown that a topical application of anthocyanin derived from Malus domestica has substantial potential for human skin system and needs some patient oriented studies could warrant its potential for damaged skin.


Subject(s)
Anthocyanins/pharmacology , Fruit , Malus , Plant Extracts/pharmacology , Sebum/drug effects , Skin/drug effects , Adult , Anthocyanins/chemistry , Chromatography, High Pressure Liquid , Emulsions , Humans , In Vitro Techniques , Male , Melanins/metabolism , Plant Extracts/chemistry , Silicones , Skin/metabolism , Skin Cream , Water Loss, Insensible/drug effects
7.
Int J Cosmet Sci ; 43(6): 729-737, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34716992

ABSTRACT

OBJECTIVE: Many endogenous or exogenous factors, isolated or combined, can trigger dry skin disorder, leading to a water/lipids-depleted stratum corneum concomitant with uncomfortable rough and scaly skin surface. In a defensive reaction, the alteration of the skin barrier stimulates the production of cytokines to initiate homeostasis restoration but this can also induce an inflammatory response that further weakens the barrier. The two phenomena intertwining one another lead to the creation of a vicious circle, here called Inflamm'dryness, that maintains dry skin state. It is thus very important to investigate biological mechanisms involved in Inflamm'dryness to better manage dry skin. METHODS: A 3D model mimicking dry skin has been developed. Adjustment of tape stripping level allowed to reproduce skin barrier alterations and resulting inflammation involved in dry skin. The effect of Helichrysum stoechas extract on this downward spiral was then investigated to validate the concept. RESULTS: Tape-stripping permitted to successively remove the cell layers of the stratum corneum: the barrier function was altered and skin was inflamed creating a vicious circle, mimicking very dry skin prone to Inflamm'dryness. Helichrysum stoechas extract was not only able to resolve inflammation but also to reverse concurrently adverse tape-stripping effects and imparted significant structural and functional recovery of the barrier (e.g. on NMF and ceramides levels, TEWL, tissue organization). CONCLUSION: This 3D model reproduces Inflamm'dryness vicious circle present in dry skin and highlights the importance of breaking this process to improve dry skin conditions. Helichrysum stoechas extract is a promising active ingredient for the management of dry skin.


OBJECTIF: De nombreux facteurs endogènes ou exogènes, isoles ou combines, peuvent être à l'origine de sècheresse cutanée, conduisant à une peau en manque d'eau et de lipides : la peau tiraille, présente parfois un l'aspect rugueux (voire la présence de squames) et des sensations d'inconfort. Cette altération de la barrière cutanée induit la production de cytokines permettant la restauration de l'homéostasie de la peau mais induisant également une réponse inflammatoire fragilisant davantage la barrière cutanée. Ces deux phénomènes conduisent à la création d'un cercle vicieux, l'Inflamm'dryness, qui entretient l'état de sécheresse de la peau. Il semble donc important d'étudier les mécanismes biologiques impliqués dans le phénomène d'Inflamm'dryness afin de mieux prendre soin des peaux sèches. MÉTHODES: Un modèle 3D mimant une peau sèche a été développé. Un ajustement du nombre de tape-strippings a été nécessaire afin de reproduire les défauts de barrière ainsi que de l'inflammation caractéristiques des peaux sèches. L'effet d'un extrait d'Helichrysum stoechas sur cette spirale négative a ensuite été étudié pour valider le concept. RÉSULTATS: L'étape de tape-stripping a permis de retirer successivement les couches superficielles du stratum corneum: la fonction barrière est altérée et la peau est enflammée créant un cercle vicieux, mimant une peau très sèche sujette à l'Inflamm'dryness. L'extrait d'Helichrysum stoechas est non seulement capable de résoudre l'inflammation, mais également de restaurer la fonction barrière de la peau (quantités de NMF et de céramides, la perte insensible en eau, organisation des tissus…). CONCLUSION: Ce modèle 3D reproduit le cercle vicieux de l'Inflamm'dryness caractéristique des peaux sèches et met en évidence l'importance de rompre ce processus afin de remédier à la sécheresse cutanée. L'extrait d'Helichrysum stoechas développé est un actif prometteur pour le soin des peaux sèches.


Subject(s)
Dehydration/drug therapy , Inflammation/drug therapy , Plant Extracts/pharmacology , Skin/drug effects , Water Loss, Insensible/drug effects , Female , Helichrysum , Humans , Middle Aged , Models, Biological
8.
Nutrients ; 13(9)2021 Sep 04.
Article in English | MEDLINE | ID: mdl-34578990

ABSTRACT

Specific partially hydrolysed whey-based infant formulas (pHF-W) have been shown to decrease the risk of atopic dermatitis (AD) in infants. Historically, AD has been associated primarily with milk allergy; however, defective skin barrier function can be a primary cause of AD. We aimed to ascertain whether oral supplementation with pHF-W can improve skin barrier function. The effect of pHF-W was assessed on transepidermal water loss (TEWL) and antibody productions in mice epicutaneously exposed to Aspergillus fumigatus. Human primary keratinocytes were stimulated in vitro, and the expression of genes related to skin barrier function was measured. Supplementation with pHF-W in neonatal mice led to a significant decrease in TEWL and total IgE, but not in allergen-specific antibody levels. The whey hydrolysate was sufficient to decrease both TEWL and total IgE. Aquaporin-3 gene expression, linked with skin hydration, was modulated in the skin of mice and human primary keratinocytes following protein hydrolysate exposure. Skin barrier improvement may be an additional mechanism by which pHF-W may potentially reduce the risk of AD development in infants. Further human studies are warranted to confirm the clinical efficacy of these observations.


Subject(s)
Dermatitis, Atopic/prevention & control , Dietary Supplements , Skin/drug effects , Whey Proteins/pharmacology , Whey/administration & dosage , Animals , Animals, Newborn , Aquaporin 3/metabolism , Humans , Hydrolysis , Immunoglobulin E/drug effects , Infant , Infant Formula , Infant, Newborn , Keratinocytes/drug effects , Mice , Skin/metabolism , Water Loss, Insensible/drug effects
9.
J Oleo Sci ; 70(9): 1325-1334, 2021 Sep 04.
Article in English | MEDLINE | ID: mdl-34373410

ABSTRACT

Dietary sphingolipids such as glucosylceramide and sphingomyelin are known to improve the skin barrier function of damaged skin. In this study, we focused on free-ceramide prepared from soy sauce lees, which is a byproduct of soy sauce production. The effects of dietary soy sauce lees ceramide on the skin of normal mice were evaluated and compared with those of dietary maize glucosylceramide. We found that transepidermal water loss value was significantly suppressed by dietary supplementation with soy sauce lees ceramide as effectively as or more effectively than maize glucosylceramide. Although the content of total and each subclass of ceramide in the epidermis was not significantly altered by dietary sphingolipids, that of 12 types of ceramide molecules, which were not present in dietary sources, was significantly increased upon ingestion of maize glucosylceramide and showed a tendency to increase with soy sauce lees ceramide intake. In addition, the mRNA expression of ceramide synthase 4 and involucrin in the skin was downregulated by sphingolipids. This study, for the first time, demonstrated that dietary soy sauce lees ceramide enhances skin barrier function in normal hairless mice, although further studies are needed to clarify the molecular mechanism.


Subject(s)
Ceramides/isolation & purification , Ceramides/pharmacology , Dietary Supplements , Epidermis/metabolism , Skin Physiological Phenomena/drug effects , Skin/metabolism , Soy Foods/analysis , Animals , Down-Regulation/drug effects , Female , Gene Expression/drug effects , Glucosylceramides/pharmacology , Mice, Hairless , Protein Precursors/genetics , Protein Precursors/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sphingolipids/pharmacology , Sphingosine N-Acyltransferase/genetics , Sphingosine N-Acyltransferase/metabolism , Water Loss, Insensible/drug effects
10.
Biomed Pharmacother ; 141: 111898, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34246188

ABSTRACT

Taurine, a sulfur-containing amino acid derivative, exists at a high concentration in the skin and is considered to play an important role in maintaining moisture homeostasis. This study investigated the effects of oral taurine supplementation on epidermal moisture content and wrinkle formation, as well as skin taurine content, using ultraviolet B (UVB)-irradiated hairless mice. Wrinkles were induced by exposing hairless mice to UVB radiation (70-100 mJ/cm2). Taurine was dissolved in drinking water at a concentration of 0.3 or 3% (w/v) and given to the mice ad libitum for 2-10 weeks. Taurine was then extracted from the dorsal skin, and the skin taurine content was determined using high-performance liquid chromatography (HPLC). The wrinkles were evaluated using a wrinkle score and the quantitative wrinkle area ratio. The exposure of the mice to UVB radiation for 4 weeks resulted in a decreased moisture content and increased transepidermal water loss (TEWL) in the skin, while taurine supplementation suppressed these changes. Oral supplementation with taurine for 8 weeks ameliorated the development of UVB-induced wrinkle formation. Furthermore, oral taurine supplementation for 4 weeks decreased pre-stablished wrinkles in a dose-dependent manner. Although the UVB radiation reduced the epidermal taurine content, oral taurine supplementation partly restored the taurine content in the epidermis. The present study showed that oral taurine supplementation is able to suppress UVB-induced wrinkle formation, which may be associated with the regulation of moisture content in the epidermis. The beneficial effects of taurine on skin aging may be attributed to its osmoregulatory role.


Subject(s)
Radiation-Protective Agents/therapeutic use , Skin Aging/drug effects , Skin Aging/radiation effects , Taurine/therapeutic use , Ultraviolet Rays , Animals , Dietary Supplements , Epidermis/drug effects , Epidermis/radiation effects , Male , Mice , Mice, Hairless , Osmoregulation/drug effects , Taurine/metabolism , Water Loss, Insensible/drug effects , Water Loss, Insensible/radiation effects
11.
J Drugs Dermatol ; 20(6): 630-632, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-34076389

ABSTRACT

BACKGROUND: Inflammatory papulopustular rosacea produces sensitive facial skin. Thus, medications designed for rosacea require careful vehicle development to insure optimal drug delivery in an environment suitable for barrier repair. OBJECTIVE: The objective of this phase 1 study was to elucidate the barrier effects of an investigational topical minocycline anhydrous gel 3% in subjects with inflammatory rosacea. METHODS: 31 male or female subjects with all complexion types and moderate facial rosacea, defined as 15+ inflammatory facial lesions, were enrolled in this single-site study to evaluate the effects of an investigational topical 3% minocycline anhydrous gel vehicle on skin barrier function; the new topical minocycline gel is an investigational product under development and has completed a phase 2b study in rosacea patients. Following a 30-minute acclimation period, subjects underwent a one-minute transepidermal water loss (TEWL) measurement on the left cheek and triplicate pin probe corneometry measurements from the right cheek. Subjects used the investigational topical 3% minocycline anhydrous gel every evening and returned to the research center at day 1, week 2, and week 4. RESULTS: 30/31 subjects completed the research study. The study medication produced a 23% (P=0.003) increase in skin hydration at day 1 and maintained the hydration increase with a 22% (P=0.003) increase at week 2 and a 20% increase (P=0.001) at week 4. Simultaneously, skin barrier function also improved with an 11% reduction in TEWL at day 1 followed by an 18% reduction in TEWL at week 2 (P=0.001) and a 28% decrease in TEWL at week 4 (P<0.001). This improvement in skin barrier was due to a combination of skin healing and the moisturizing properties of the investigational topical 3% minocycline anhydrous gel medication evaluated in this study. CONCLUSION: The investigational topical 3% minocycline anhydrous gel decreases TEWL, indicating barrier repair, while increasing corneometry measurements, indicating improved skin hydration. J Drugs Dermatol. 2021;20(6):630-632. doi:10.36849/JDD.6105Visit the rosacea resource center.


Subject(s)
Rosacea , Dermatologic Agents/pharmacology , Female , Humans , Male , Minocycline/pharmacology , Rosacea/diagnosis , Rosacea/drug therapy , Skin , Treatment Outcome , Water Loss, Insensible/drug effects
12.
Molecules ; 26(9)2021 May 10.
Article in English | MEDLINE | ID: mdl-34068613

ABSTRACT

Nowadays, natural dyes are expected by the cosmetic and food industries. In contrast to synthetic dyes, colorants derived from natural sources are more environmentally friendly and safer for human health. In this work, plant extracts from Gomphrena globasa L., Clitoria ternatea L., Carthamus tinctorius L., Punica granatum L. and Papaver rhoeas L. as the natural and functional dyes for the cosmetics industry were assessed. Cytotoxicity on keratinocyte and fibroblast cell lines was determined as well as antioxidant and anti-aging properties by determining their ability to inhibit the activity of collagenase and elastase enzymes. In addition, the composition of the extracts was determined. The obtained extracts were also applied in face cream formulation and color analyses were performed. It has been shown that the obtained extracts were characterized by no cytotoxicity and a high antioxidant potential. The extracts also show strong ability to inhibit the activity of collagenase and moderate ability to inhibit elastase and provide effective and long-lasting hydration after their application on the skin. Application analyses showed that the extracts of P. rhoeas L., C. ternatea L. and C. tinctorius L. can be used as effective cosmetic dyes that allow for attainment of an intense and stable color during the storage of the product. The extracts of P. granatum L. and G. globasa L., despite their beneficial effects as active ingredients, did not work effectively as cosmetic dyes, because cosmetic emulsions with these extracts did not differ significantly in color from emulsions without the extract.


Subject(s)
Antioxidants/pharmacology , Coloring Agents/pharmacology , Cosmetics/pharmacology , Cytoprotection , Desiccation , Flowers/chemistry , Plant Extracts/pharmacology , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Cell Death/drug effects , Collagenases/metabolism , Color , Cytoprotection/drug effects , HaCaT Cells , Humans , Kinetics , Matrix Metalloproteinase Inhibitors/pharmacology , Oxazines/metabolism , Pancreatic Elastase/antagonists & inhibitors , Pancreatic Elastase/metabolism , Picrates/chemistry , Plants/chemistry , Skin Cream/pharmacology , Sulfonic Acids/chemistry , Ultraviolet Rays , Water Loss, Insensible/drug effects , Xanthenes/metabolism
13.
Sci Rep ; 11(1): 11920, 2021 06 07.
Article in English | MEDLINE | ID: mdl-34099793

ABSTRACT

Excess glucocorticoids (GCs) with either endogenous or exogenous origins deteriorate skin barrier function. GCs bind to mineralocorticoid and GC receptors (MRs and GRs) in normal human epidermal keratinocytes (NHEKs). Inappropriate MR activation by GCs mediates various GC-induced cutaneous adverse events. We examined whether MR antagonists can ameliorate GC-mediated skin barrier dysfunction in NHEKs, reconstructed human epidermis (RHE), and subjects under psychological stress (PS). In a preliminary clinical investigation, topical MR antagonists improved skin barrier function in topical GC-treated subjects. In NHEKs, cortisol induced nuclear translocation of GR and MR, and GR and MR antagonists inhibited cortisol-induced reductions of keratinocyte differentiation. We identified 7,3',4'-trihydroxyisoflavone (7,3',4'-THIF) as a novel compound that inhibits MR transcriptional activity by screening 30 cosmetic compounds. 7,3',4'-THIF ameliorated the cortisol effect which decreases keratinocyte differentiation in NHEKs and RHE. In a clinical study on PS subjects, 7,3',4'-THIF (0.1%)-containing cream improved skin barrier function, including skin surface pH, barrier recovery rate, and stratum corneum lipids. In conclusion, skin barrier dysfunction owing to excess GC is mediated by MR and GR; thus, it could be prevented by treatment with MR antagonists. Therefore, topical MR antagonists are a promising therapeutic option for skin barrier dysfunction after topical GC treatment or PS.


Subject(s)
Glucocorticoids/pharmacology , Isoflavones/pharmacology , Mineralocorticoid Receptor Antagonists/pharmacology , Receptors, Mineralocorticoid/metabolism , Skin/drug effects , Active Transport, Cell Nucleus/drug effects , Administration, Cutaneous , Animals , Cell Differentiation/drug effects , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cells, Cultured , Epidermis/drug effects , Epidermis/metabolism , Glucocorticoids/metabolism , Humans , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Lipids/analysis , Permeability/drug effects , Receptors, Mineralocorticoid/genetics , Skin/metabolism , Skin/physiopathology , Water Loss, Insensible/drug effects , Water Loss, Insensible/physiology
14.
J Dermatol Sci ; 102(3): 142-157, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34116898

ABSTRACT

Atopic dermatitis (AD) is a chronic, inflammatory skin disorder characterized by eczematous and pruritic skin lesions. In recent decades, the prevalence of AD has increased worldwide, most notably in developing countries. The enormous progress in our understanding of the complex composition and functions of the epidermal barrier allows for a deeper appreciation of the active role that the skin barrier plays in the initiation and maintenance of skin inflammation. The epidermis forms a physical, chemical, immunological, neuro-sensory, and microbial barrier between the internal and external environment. Not only lesional, but also non-lesional areas of AD skin display many morphological, biochemical and functional differences compared with healthy skin. Supporting this notion, genetic defects affecting structural proteins of the skin barrier, including filaggrin, contribute to an increased risk of AD. There is evidence to suggest that natural environmental allergens and man-made pollutants are associated with an increased likelihood of developing AD. A compromised epidermal barrier predisposes the skin to increased permeability of these compounds. Numerous topical and systemic therapies for AD are currently available or in development; while anti-inflammatory therapy is central to the treatment of AD, some existing and novel therapies also appear to exert beneficial effects on skin barrier function. Further research on the skin barrier, particularly addressing epidermal differentiation and inflammation, lipid metabolism, and the role of bacterial communities for skin barrier function, will likely expand our understanding of the complex etiology of AD and lead to identification of novel targets and the development of new therapies.


Subject(s)
Dermatitis, Atopic/immunology , Dermatologic Agents/pharmacokinetics , Epidermis/pathology , Microbiota/immunology , Cell Differentiation/drug effects , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/pathology , Dermatologic Agents/therapeutic use , Drug Development , Epidermis/drug effects , Epidermis/immunology , Filaggrin Proteins , Humans , Lipid Metabolism/drug effects , Lipid Metabolism/immunology , Microbiota/drug effects , Permeability/drug effects , Water Loss, Insensible/drug effects , Water Loss, Insensible/immunology
15.
J Drugs Dermatol ; 20(4): 384-392, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33852244

ABSTRACT

BACKGROUND: Rosacea, an inflammatory skin disease that leads to an impaired skin barrier function commonly involves the face. Symptoms of rosacea can be bothersome and include pain, stinging, burning, itching, and facial flushing. This review explored skin barrier impairment in rosacea and reduced symptomatology when using over the counter (OTC) skincare products. METHODS: Nine dermatologists (the panel) completed a survey on OTC products they recommend for rosacea. The survey results were summarized, presented, and discussed during the online meeting, together with the results of a literature review. The outcome of these discussions, coupled with the panel's expert opinion and experience, is shown in the current review. RESULTS: Addressing barrier dysfunction by use of moisturizer and cleanser formulations that restore skin hydration, normalize skin pH, restore the microbiome, and skin lipids can assist in improving rosacea signs and symptoms. The panel's consensus was that in addition to the use of prescription medications, skincare recommendations are a crucial part of successful rosacea therapy. In addition to occlusives and humectants, barrier restoring ingredients such as ceramides, hyaluronic acid, and niacinamide were considered beneficial. Equally important was the absence of potentially irritating substances. CONCLUSIONS: The use of OTC products can improve rosacea symptomatology and signs. As adjuncts, these products are recommended before and during prescription therapy and as part of a maintenance regimen. J Drugs Dermatol. 20(4):384-392. doi:10.36849/JDD.5861 THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE. PLEASE SCROLL DOWN TO ACCESS THE FULL fTEXT OF THIS ARTICLE WITHOUT LOGGING IN. NO PURCHASE NECESSARY. PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.


Subject(s)
Dermatologic Agents/administration & dosage , Nonprescription Drugs/administration & dosage , Prescription Drugs/administration & dosage , Rosacea/therapy , Skin Care/methods , Administration, Cutaneous , Combined Modality Therapy/methods , Combined Modality Therapy/standards , Consensus , Dermatology/methods , Dermatology/standards , Humans , Microbiota/drug effects , Practice Guidelines as Topic , Rosacea/microbiology , Rosacea/pathology , Severity of Illness Index , Skin/drug effects , Skin/microbiology , Skin/pathology , Skin Care/standards , Treatment Outcome , Water Loss, Insensible/drug effects
16.
J Drugs Dermatol ; 20(4): s3-s9, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33852254

ABSTRACT

Skin is a complex organ comprised of multiple cell types and microstructures that work in concert to serve critical functions and support the body’s homeostasis. It is the outermost, cornified layer of our body that is primarily responsible for the permeability barrier, protecting against external aggressors and preventing water loss from within. The understanding of the organization, functionality, and underlying mechanisms of the skin barrier has evolved greatly through the years. The formation of an intact and well-maintained stratum corneum (SC), where the permeability barrier resides, relies heavily on the differentiation of epidermal keratinocytes and the synthesis, release, localization, and binding of lipids that include principally ceramides, cholesterol, and free fatty acids. The in-depth research on SC barrier, its disruption in the pathogenesis of diseases, as well as on barrier responses to environmental insults, has enabled the development of modern therapeutics and topical care routines. Among them, ceramide-containing moisturizers have clinically demonstrated the ability to support the management of skin conditions such as atopic dermatitis and psoriasis by reducing the disease severity and recurrence and improving the patients’ perception of overall skin quality and health. This review focuses on the contributions of various barrier constituents to skin barrier function in health and pathological conditions, and how topical interventions containing essential barrier lipids support barrier restoration and provide relief. J Drugs Dermatol. 20(4 Suppl):s3-9. doi:10.36849/JDD.S589A.


Subject(s)
Ceramides/administration & dosage , Dermatitis, Atopic/drug therapy , Emollients/administration & dosage , Epidermis/pathology , Psoriasis/drug therapy , Administration, Cutaneous , Cell Differentiation/drug effects , Ceramides/metabolism , Cholesterol/metabolism , Dermatitis, Atopic/pathology , Epidermis/drug effects , Fatty Acids, Nonesterified/metabolism , Humans , Keratinocytes/physiology , Lipid Metabolism/drug effects , Permeability , Psoriasis/pathology , Water Loss, Insensible/drug effects
17.
J Drugs Dermatol ; 20(4): 23s-28s, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33852257

ABSTRACT

Dynamic changes to the skin barrier’s molecular structure and ceramide profile are well-documented in skin conditions such as atopic dermatitis and psoriasis. Pathological and environmental factors have been shown to impair barrier integrity and demonstrate shifts in ceramide composition in the skin. However, the relationship between acute and prolonged sun exposure and its effects on skin barrier homeostasis is insufficiently investigated. This study aims to uncover new scientific evidence to elucidate the relationship of UV irradiation with the skin barrier using an ex vivo tissue model following simulated UVA/UVB exposure. Fresh ex vivo human skin pretreated either with or without a broad-spectrum sunscreen was exposed to either a physiological or elevated UV condition. Following eight days in culture, structural and molecular changes were evaluated. UV irradiated skin displayed epidermal cell death and altered expression of key barrier proteins. TEM analysis demonstrated disruption to adherens junctions and dissociation between tissue layers following both physiological and extensive UV exposures. An effective broad-spectrum sunscreen containing essential skin ceramides completely protected the skin from such changes. This is one of the first works demonstrating a clear correlation of altered skin barrier integrity using a physiologically relevant dose in an ex vivo tissue model. Our findings also further support the additional importance and benefits of sun protection among the consumers. J Drugs Dermatol. 20(4 Suppl):s23-28. doi:10.36849/JDD.S589D.


Subject(s)
Skin/radiation effects , Sunscreening Agents/administration & dosage , Ultraviolet Rays/adverse effects , Adult , Female , Humans , Male , Middle Aged , Skin/drug effects , Sun Protection Factor , Sunscreening Agents/chemistry , Tissue Culture Techniques , Water Loss, Insensible/drug effects , Water Loss, Insensible/radiation effects
18.
J Drugs Dermatol ; 20(4): s10-s16, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33852255

ABSTRACT

The skin barrier is a multifaceted microenvironment, comprised not only of structural and molecular components that maintain its integrity, but also a lipid matrix comprising an equimolar ratio of cholesterol, free fatty acids, and ceramides. Lipid abnormalities induced by environmental or pathological stimuli are often associated with impaired skin barrier function and integrity. Incorporation of skin lipids in skincare formulations to help fortify barrier function has become widespread. While there are resources available to study the barrier, a comprehensive evaluation of skin models, from in situ to in vivo, that focus on alterations of the lipid content, seems to be lacking. This article reviews current methods to evaluate the skin lipid barrier and touches upon the significance of using such models within the cosmetic field to study formulations that incorporate barrier lipids. J Drugs Dermatol. 20(4 Suppl):s10-16. doi:10.36849/JDD.S589B.


Subject(s)
Cosmetics/administration & dosage , Emollients/administration & dosage , Epidermis/drug effects , Skin Care/methods , Animals , Cell Culture Techniques , Cell Line , Ceramides/administration & dosage , Ceramides/metabolism , Cholesterol/administration & dosage , Cholesterol/metabolism , Cosmetics/chemistry , Disease Models, Animal , Emollients/chemistry , Epidermis/physiology , Epidermis/radiation effects , Fatty Acids, Nonesterified/administration & dosage , Fatty Acids, Nonesterified/metabolism , Humans , Tissue Culture Techniques , Ultraviolet Rays/adverse effects , Water Loss, Insensible/drug effects
19.
J Drugs Dermatol ; 20(4): s29-s35, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33852258

ABSTRACT

The human skin, particularly the stratum corneum, serves as a protective barrier against exogenous factors, including ultraviolet radiation (UVR) and pathogen invasions. The impact of UVR on skin cancer and photoaging has been extensively studied. However, the direct impact of UVR on skin barrier integrity under clinical settings remains poorly explored. Due to their benefits in reducing inflammation and promoting skin barrier repair, ceramide-containing formulations can provide added photoprotection benefits. In this study, the efficacy of a ceramide-containing sunscreen and moisturizer were evaluated in preventing UV-induced skin surface barrier changes. Expert grading, instrumental, and tape-stripping assessments demonstrated that UVR induced erythema and hyperpigmentation and caused changes in skin cells surface morphological organization and maturation. Treatment with a ceramide-containing sunscreen and moisturizing cream routine reduced erythema and hyperpigmentation, improved skin hydration, and maintained normal superficial skin cells morphology and turnover after UVR. Our results indicate that barrier-enforcing lipids formulations can provide additional benefits in patient’s daily routine by strengthening the barrier and improving skin health overall against chronic sun exposure. J Drugs Dermatol. 20(4 Suppl):s29-35. doi:10.36849/JDD.S589E.


Subject(s)
Ceramides/administration & dosage , Erythema/prevention & control , Hyperpigmentation/prevention & control , Ultraviolet Rays/adverse effects , Adolescent , Adult , Emollients/administration & dosage , Emollients/chemistry , Erythema/diagnosis , Erythema/etiology , Erythema/pathology , Female , Healthy Volunteers , Humans , Hyperpigmentation/diagnosis , Hyperpigmentation/etiology , Hyperpigmentation/pathology , Male , Middle Aged , Photography , Skin/diagnostic imaging , Skin/drug effects , Skin/radiation effects , Skin Aging/drug effects , Skin Aging/radiation effects , Sunscreening Agents/administration & dosage , Sunscreening Agents/chemistry , Treatment Outcome , Water Loss, Insensible/drug effects , Water Loss, Insensible/radiation effects , Young Adult
20.
J Drugs Dermatol ; 20(3): 295-301, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33683070

ABSTRACT

Acne vulgaris is the most common dermatological disorder worldwide, causing significant physical and psychological morbidity. Topical combination therapy has shown superior efficacy compared to monotherapy, especially when combined with retinoids. Few studies have directly compared combined formulations. This evaluator-blinded pilot study compared the efficacy and tolerability of two marketed topical combination acne gels, clindamycin 1%-tretinoin 0.025% (CT) and benzoyl peroxide 2.5%-adapalene 0.1% (BA) in 20 patients with mild to moderate acne vulgaris. Gels were applied daily on opposite sides of the face for 21 days. The primary outcome was difference in transepidermal water loss (TEWL) at the end of treatment. Secondary endpoints were skin moisture content measurement, Investigators' Global Assessment, subject self-assessments (SSA) of burning/stinging, itching, erythema, and dryness/scaling, and Comparative Participant Satisfaction Questionnaire (CPSQ). Efficacy was assessed by inflammatory and non- inflammatory acne efflorescences counts. TEWL increased significantly for both CT and BA (+57.74%, P=0.002; +58.77%, P<0.001); skin moisture content significantly decreased only for BA (-16.47%, P=0.02). Only BA showed a significant increase in erythema and dryness/scaling (P=0.027 and P=0.014) and in SSA burning/stinging (P=0.04). Patient satisfaction evaluation also reflected the strong BA irritation. Although CT and BA both reduced acne lesions (P<0.001) and more patients preferred to continue with CT, subject perception of acne improvement was higher for BA. These findings suggest that CT and BA have similar efficacy in the treatment of mild to moderate papulopustular acne. However, CT was better tolerated than BA by both medical and subject evaluation. CT is an effective and tolerated treatment option.J Drugs Dermatol. 2021;20(3):295-301. doi:10.36849/JDD.2021.5641.


Subject(s)
Acne Vulgaris/drug therapy , Adapalene, Benzoyl Peroxide Drug Combination/administration & dosage , Clindamycin/administration & dosage , Dermatologic Agents/administration & dosage , Tretinoin/administration & dosage , Acne Vulgaris/diagnosis , Adapalene, Benzoyl Peroxide Drug Combination/adverse effects , Administration, Cutaneous , Adolescent , Adult , Clindamycin/adverse effects , Dermatologic Agents/adverse effects , Drug Combinations , Erythema/chemically induced , Erythema/epidemiology , Female , Gels , Humans , Male , Patient Satisfaction/statistics & numerical data , Pilot Projects , Pruritus/chemically induced , Pruritus/epidemiology , Severity of Illness Index , Skin/drug effects , Treatment Outcome , Tretinoin/adverse effects , Water Loss, Insensible/drug effects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...